Samar J. Almehmadi

Samar J. Almehmadi

Auto-generated profile, based on publicly available information

Samar J. Almehmadi

Department of Chemistry College of Science, Umm Al‐Qura University Makkah Saudi Arabia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2024 in Bioorganic Chemistry
Verified
Journal Article
Closed access
SASamar J. Almehmadi
Samar J. Almehmadi
RSRehab Sabour
Rehab Sabour
AKAsmaa F. Kassem
Asmaa F. Kassem
EAEman M.H. Abbas
Eman M.H. Abbas
AAAmani M.R. Alsaedi
Amani M.R. Alsaedi
TFThoraya Farghaly
Thoraya Farghaly

8 June 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
LELamiaa O. El-Halaby
Lamiaa O. El-Halaby
NENada F Abo El-Magd
Nada F Abo El-Magd
SASamar J. Almehmadi
Samar J. Almehmadi
AEAhmed El-Sayed
Ahmed El-Sayed
RKReham R. Khattab
Reham R. Khattab
SESherin Elfeky
Sherin Elfeky

20 August 2025 in Journal of Molecular Structure
Verified
Journal Article
Open access
STSamar S. Tawfik
Samar S. Tawfik
EEEslam Elhanafy
Eslam Elhanafy
SASamar J. Almehmadi
Samar J. Almehmadi
WEWafaa A. Ewes
Wafaa A. Ewes
AEAhmed Elkamhawy
Ahmed Elkamhawy
SESherin Elfeky
Sherin Elfeky

12 April 2026 in Journal of Molecular Structure
Verified
Journal Article
Closed access
SAShorog M. Alotaiby
Shorog M. Alotaiby
SASara A. Alqarni
Sara A. Alqarni
Adel Ibrahim AlAlawyAdel Ibrahim AlAlawy
Adel Ibrahim AlAlawy
SASamar J. Almehmadi
Samar J. Almehmadi
Manal S. EbaidManal S. Ebaid
Manal S. Ebaid
NENashwa M. El-Metwaly
Nashwa M. El-Metwaly

15 July 2026 in Chemical Biology & Drug Design
Verified
Journal Article
Open access
NENashwa Elmetwaly
Nashwa Elmetwaly
AAAbdulmajeed Fahad Alrefaei
Abdulmajeed Fahad Alrefaei
HAhossa alshareef
hossa alshareef
SASamar J. Almehmadi
Samar J. Almehmadi
FAFatimah A. Alotaibi
Fatimah A. Alotaibi
HKHanadi A. Katouah
Hanadi A. Katouah
The design, synthesis, and biological assessment of new heterocyclic compounds containing the 1,3,4‐thiadiazole moiety, a well‐known pharmacophore with substantial medicinal significance, are the main topics of this study. To create a variety of thiadiazole‐based heterocyclic systems, such as pyrazoles, triazoles, pyrimidines, and thiophenes, a novel cyanoacetohydrazide derivative was created and used as a crucial intermediate. IR, 1 H‐NMR, 13 C‐NMR, and mass spectrometry were the spectroscopic methods used to confirm the structures of produced compounds. The synthesized compounds' biological properties were assessed for their potential as antioxidants and anticancer agents. Several derivatives showed impressive activity in cytotoxicity tests against HePG‐2 and MCF‐7 cancer cell lines, with several compounds showing greater potency than the reference medication 5‐fluorouracil. Compounds 17 , 18 , and 13 exhibited the strongest anticancer activity, highlighting the significance of structural and electronic properties in improving biological performance. Furthermore, an assessment of the synthesized compounds' antioxidant activity revealed that they have differing levels of free radical scavenging activity, with compounds 17 and 18 exhibiting the most notable benefits, albeit still less than ascorbic acid. Electron‐donating and electron‐withdrawing groups, molecular conjugation, and lipophilicity all play a part in regulating antioxidant and anticancer actions, according to structure–activity relationship (SAR) studies. Additionally, substantial interactions between specific drugs and the EGFR tyrosine kinase domain were suggested by molecular docking studies, indicating their possible mode of action. All things considered, our work shows that thiadiazole‐based heterocycles are attractive candidates for the creation of novel antioxidants and anticancer medicines and offers insightful information for future drug design.